The prevention and control of cardiovascular disease starts with an accurate risk assessment. The Aviir TruRisk™ assessment reveals actual cardiovascular risk.
Many physicians today utilize the Framingham Risk Score (or other risk scores), a combination of various tests, and/or traditional risk factors to determine the cardiovascular risk of their patients. Patients falling in the low and high risk groups are easily defined and managed based on current guidelines. But, classification and management of the intermediate risk group is not as clearly defined – leaving patients in this group at risk. The Aviir TruRisk™ assessment has been developed to aid in further defining the risk of the intermediate risk groups.
Why is this important?
Studies have shown that 62% of all cardiac events happen to people who have only 0 to 1 of the traditional risk factors. In fact, 15% of women and 19% of men having heart attacks have NO risk factors.1 We also know that approximately 50% of individuals having heart attacks have normal LDL (cholesterol) levels.2 The Guidelines for Assessment of Cardiovascular Risk in Asymptomatic Adults recommends further testing for intermediate risk patients to further define risk status.3
Clearly, there is a need to more accurately define the true risk of patients that fall into the intermediate risk group.
By objectively reclassifying those patients at high risk, the Aviir TruRisk assessment may allow physicians to manage and treat this group more effectively --aiding in the reduction and prevention of cardiac events. Used in conjunction with other clinical information, the TruRisk assessment may assist the physician to motivate compliance and behavioral changes with their patients through an easy to understand risk score for the imminent 5 year horizon.
The proprietary Aviir TruRisk assessment employs a complex algorithm using a set of unique biomarkers that measures the underlying pathogenesis of cardiovascular disease.
Just a simple blood draw is needed to produce a risk score that is presented as a percent chance of having a cardiac event (myocardial infarction or unstable angina) in the next 5 years.
Aviir makes it easy for you to integrate the TruRisk assessment into your current approach for Cardiovascular Risk Assessment.
We provide a concise report format to make interpretation of the results relevant and clear.
1 Khot, et.al “Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease,” JAMA, Vol. 290, No. 7; 2003.
2 Sachdeva et.al. “Lipid levels in patients hospitalized with coronary artery disease: Analysis of 136,905 hospitalizations in Get With the Guidelines”, AMJ, Vol. 157, Issue 1; 2009.
3 Greenland et.al. “2010 ACC/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines”, Circulation, Vo. 56, No. 25; 2010.
